Auxly Cannabis Group Inc.

TSX:XLY.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$3.53 +0.00%

+$0.00 today

Market cap
$364.42M
Beta
1.16
P/E (TTM)
7.3
EPS (TTM)
$0.02
52W Low $0.08High $0.19

Volume 0.13M

Average 0.71M

XLY.TO Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Auxly Cannabis Group Inc.TSX: XLY.TO

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q1 FY2026 weighted avg shares of 1.38B shares rose 5.1% year over year, in line with the +5.3% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 2.0% from the prior quarter. Over 3 fiscal years it compounded at +14.3% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +5.1% toward the trailing-twelve-month pace of +5.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
1.38B+2.0% QoQ
Last fiscal yearDec 2025
1.33B+10.4% YoY
LTMMar 2026
1.35B+5.3% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5.1%——
1 year+10.4%——
3-year CAGR+14.3%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
1.33B CAD
Year-over-year change
+10.4%
4-year CAGR
+14.1%

Weighted Avg Shares vs competitors

How XLY.TO compares with its peers on the latest reported figures

  • XLY.TO's LTM Mar 2026 weighted avg shares of 1.35B shares is the highest of the 4 companies compared; the peer median is 62.94M shares.
  • Its year-over-year change of +5.3% is the 2nd highest of 4, against a peer median of +2.7%.
  • Over three fiscal years its annual growth of +14.3% compares with a peer median of +9.6%.
XLY.TO Competitors Peer median
Weighted Avg Shares for XLY.TO and competitors
Company Period LTM YoY 3-year CAGR
XLY.TOAuxly Cannabis Group Inc.LTM Mar 20261.35B +5.3%+14.3%
CRDL.TOCardiol Therapeutics Inc.LTM Mar 202694.16M +24.3%+11.6%
CRRX.TOCareRx CorporationLTM Mar 202662.94M +2.7%+9.6%
HLS.TOHLS Therapeutics Inc.LTM Mar 202631.4M -0.7%-0.8%
Peer median (excluding XLY.TO) 62.94M+2.7%+9.6%

Competitors are the stored peer set for XLY.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue83.83M94.47M101.08M122.33M151.48M
Cost of Revenue64.54M77.96M79.8M62.4M64.74M
Gross Profit19.29M16.51M21.28M59.93M86.74M
Gross Margin23.0%17.5%21.1%49.0%57.3%
Research & Development298K292K497K00
Selling, General & Admin45.42M50.38M40.28M40.73M49.07M
Operating Expenses58.23M65.49M47.23M45.22M54.07M
Depreciation & Amortization14.27M20.18M11.21M10.28M11.45M
EBITDA(18.3M)(94.79M)(10.89M)24.38M50.31M
EBITDA Margin-21.8%-100.3%-10.8%19.9%33.2%
Operating Income(38.94M)(48.98M)(25.95M)14.71M32.67M
Operating Margin-46.4%-51.8%-25.7%12.0%21.6%
Interest Income1.59M337K32K240K130K
Interest Expense17.67M21.58M25.65M14.46M6.34M
Other Income / Expenses(11.3M)(87.58M)(21.8M)(15.07M)(155K)
Income Before Tax(50.24M)(136.56M)(47.75M)(356K)32.52M
Pre-Tax Margin-59.9%-144.5%-47.2%-0.3%21.5%
Income Tax Expense(4.33M)(6.26M)(3.24M)15.99M(9.34M)
Net Income(33.74M)(130.29M)(44.51M)(16.35M)41.86M
Net Margin-40.2%-137.9%-44.0%-13.4%27.6%
EPS (Basic)(0.06)(0.15)(0.04)(0.01)0.03
EPS (Diluted)(0.06)(0.15)(0.04)(0.01)0.03
Weighted Avg Shares783.38M889.87M990.99M1.2B1.33B
Weighted Avg Shares (Diluted)783.38M889.87M990.99M1.2B1.59B

Auxly Cannabis Group Inc.

TSX:XLY.TO

Intrinsic Alpha fair value

Locked

Current Price

$3.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.